Report overview
This report contains market size and forecasts of Cancer Anorexia-Cachexia Syndrome Drug in global, including the following market information:
Global Cancer Anorexia-Cachexia Syndrome Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Cancer Anorexia-Cachexia Syndrome Drug companies in 2021 (%)
The global Cancer Anorexia-Cachexia Syndrome Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NEO-1940 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Anorexia-Cachexia Syndrome Drug include Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd and RaQualia Pharma Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Anorexia-Cachexia Syndrome Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Anorexia-Cachexia Syndrome Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, by Type, 2021 (%)
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others
Global Cancer Anorexia-Cachexia Syndrome Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Cancer Anorexia-Cachexia Syndrome Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Anorexia-Cachexia Syndrome Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Anorexia-Cachexia Syndrome Drug revenues share in global market, 2021 (%)
Key companies Cancer Anorexia-Cachexia Syndrome Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Cancer Anorexia-Cachexia Syndrome Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
